Literature DB >> 23760095

Plasma interferon-gamma-inducible protein 10 can be used to predict viral load in HIV-1-infected individuals.

Clive M Gray, Heather A Hong, Katherine Young, David A Lewis, Dorothy Fallows, Claudia Manca, Gilla Kaplan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23760095      PMCID： PMC3682795          DOI： 10.1097/QAI.0b013e3182930ea8

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN： 1525-4135            Impact factor:   3.731


× No keyword cloud information.
  9 in total

1.  The suppression of immune activation during enfuvirtide-based salvage therapy is associated with reduced CCR5 expression and decreased concentrations of circulating interleukin-12 and IP-10 during 48 weeks of longitudinal follow-up.

Authors:  H Carsenti-Dellamonica; H Saïdi; M Ticchioni; F Guillouet de Salvador; J Dufayard Cottalorda; R Garraffo; P Dellamonica; J Durant; M-L Gougeon
Journal:  HIV Med       Date:  2011-02       Impact factor: 3.180

2.  Genital Inflammation Predicts HIV-1 Shedding Independent of Plasma Viral Load and Systemic Inflammation.

Authors:  Catherine A Blish; R Scott McClelland; Barbra A Richardson; Walter Jaoko; Kishorchandra Mandaliya; Jared M Baeten; Julie Overbaugh
Journal:  J Acquir Immune Defic Syndr       Date:  2012-12-01       Impact factor: 3.731

3.  Cerebrospinal fluid interferon-gamma-inducible protein 10 (IP-10, CXCL10) in HIV-1 infection.

Authors:  Paola Cinque; Arabella Bestetti; Roberta Marenzi; Serena Sala; Magnus Gisslen; Lars Hagberg; Richard W Price
Journal:  J Neuroimmunol       Date:  2005-08-08       Impact factor: 3.478

4.  Plasma IP-10 is associated with rapid disease progression in early HIV-1 infection.

Authors:  Yanmei Jiao; Tong Zhang; Rui Wang; Hongwei Zhang; Xiaojie Huang; Jiming Yin; Liguo Zhang; Xiaoning Xu; Hao Wu
Journal:  Viral Immunol       Date:  2012-07-12       Impact factor: 2.257

5.  Plasma interferon-gamma-inducible protein-10 (IP-10) levels during acute hepatitis C virus infection.

Authors:  Jason Grebely; Jordan J Feld; Tanya Applegate; Gail V Matthews; Margaret Hellard; Alana Sherker; Kathy Petoumenos; Geng Zang; Ineke Shaw; Barbara Yeung; Jacob George; Suzy Teutsch; John M Kaldor; Vera Cherepanov; Julie Bruneau; Naglaa H Shoukry; Andrew R Lloyd; Gregory J Dore
Journal:  Hepatology       Date:  2013-05-08       Impact factor: 17.425

6.  Interferon gamma-inducible protein 10: a predictive marker of successful treatment response in hepatitis C virus/HIV-coinfected patients.

Authors:  Marija Zeremski; Marianthi Markatou; Queenie B Brown; Gary Dorante; Susanna Cunningham-Rundles; Andrew H Talal
Journal:  J Acquir Immune Defic Syndr       Date:  2007-07-01       Impact factor: 3.731

7.  Acute plasma biomarkers of T cell activation set-point levels and of disease progression in HIV-1 infection.

Authors:  Anne-Sophie Liovat; Marie-Anne Rey-Cuillé; Camille Lécuroux; Béatrice Jacquelin; Isabelle Girault; Gaël Petitjean; Yasmine Zitoun; Alain Venet; Françoise Barré-Sinoussi; Pierre Lebon; Laurence Meyer; Martine Sinet; Michaela Müller-Trutwin
Journal:  PLoS One       Date:  2012-10-02       Impact factor: 3.240

8.  Effect of standard tuberculosis treatment on plasma cytokine levels in patients with active pulmonary tuberculosis.

Authors:  Catherine Riou; Blas Perez Peixoto; Lindi Roberts; Katharina Ronacher; Gerhard Walzl; Claudia Manca; Roxana Rustomjee; Thuli Mthiyane; Dorothy Fallows; Clive M Gray; Gilla Kaplan
Journal:  PLoS One       Date:  2012-05-14       Impact factor: 3.240

9.  The expression of a gamma interferon-induced protein (IP-10) in delayed immune responses in human skin.

Authors:  G Kaplan; A D Luster; G Hancock; Z A Cohn
Journal:  J Exp Med       Date:  1987-10-01       Impact factor: 14.307
  9 in total
  3 in total

1.  High IP-10 levels decrease T cell function in HIV-1-infected individuals on ART.

Authors:  L A Ramirez; T A Arango; E Thompson; M Naji; P Tebas; J D Boyer
Journal:  J Leukoc Biol       Date:  2014-08-25       Impact factor: 4.962

2.  Interferon Alpha Subtype-Specific Suppression of HIV-1 Infection In Vivo.

Authors:  Kerry J Lavender; Kathrin Gibbert; Karin E Peterson; Erik Van Dis; Sandra Francois; Tyson Woods; Ronald J Messer; Ali Gawanbacht; Janis A Müller; Jan Münch; Katie Phillips; Brent Race; Michael S Harper; Kejun Guo; Eric J Lee; Mirko Trilling; Hartmut Hengel; Jacob Piehler; Jens Verheyen; Cara C Wilson; Mario L Santiago; Kim J Hasenkrug; Ulf Dittmer
Journal:  J Virol       Date:  2016-06-10       Impact factor: 5.103

3.  Biomarkers of Progression after HIV Acute/Early Infection: Nothing Compares to CD4⁺ T-cell Count?

Authors:  Gabriela Turk; Yanina Ghiglione; Macarena Hormanstorfer; Natalia Laufer; Romina Coloccini; Jimena Salido; César Trifone; María Julia Ruiz; Juliana Falivene; María Pía Holgado; María Paula Caruso; María Inés Figueroa; Horacio Salomón; Luis D Giavedoni; María de Los Ángeles Pando; María Magdalena Gherardi; Roberto Daniel Rabinovich; Pedro A Pury; Omar Sued
Journal:  Viruses       Date:  2018-01-13       Impact factor: 5.048
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.